Archive

This year, two ERC Consolidator grants have been awarded to TU Delft researchers. Both these researchers work at the Faculty of Applied Sciences. Dr. Pouyan Boukany from the Department of Chemical Engineering wants to learn when, how and why metastatic tumour cells detach form a tumour. Dr. Chirlmin Joo from the Department of Bionanoscience wants to develop a new gene editing tool based on a system found in a single-celled organism.

The European Molecular Biology Organization (EMBO) has selected Hyun Youk and 25 other life science researchers within their first four years as group leaders to become EMBO Young Investigators. Youk will join an active network of 102 current and 314 past Young Investigators and will receive support from EMBO during the foundation of their first independent laboratory.

Dr Marie-Eve Aubin-Tam and Dr Monique van der Veen, both of the faculty of Applied Sciences at the TU Delft, will receive the NWO Athena Prize 2018 at the CHAINS chemistry conference on 4 December.

Hyun Youk (Bionanoscience) has been selected as one of the 12 early career researchers who will join the CIFAR Azrieli Global Scholars program. Youk will receive a prestigious two‐year term with 100,000 dollar in research support.

Marileen Dogterom, Professor of Bionanoscience at TU Delft, has been awarded the NWO Spinoza Prize; the highest award in Dutch science. Dogterom carries out research into the dynamics in living cells and leads a consortium which is aiming to build an entirely artificial cell.

Marileen Dogterom (Bionanoscience) is one of seven people who will be designated as Society Fellows of the Biophysical Society.

On Monday 2 July, Cees Dekker, Professor of Molecular Biophysics at the Faculty of Applied Sciences (AS), was surprised...

What is invisible and will kill millions of people in thirty years' time? Answer: bacteria. Years of excessive use of antibiotics have enabled certain bacteria to evolve in a way that has become impossible to treat. A small group of researchers at TU Delft is working hard to find a solution.

CRISPR-Cas9 has made gene editing a lot easier and will eventually help us erase hereditary diseases from our DNA.

Researchers at Delft University of Technology, in collaboration with colleagues at the Autonomous University of Madrid, have created an artificial DNA blueprint for the replication of DNA in a cell-like structure.